CCM
PFE icon

Coerente Capital Management’s Pfizer PFE Stock Holding History

Coerente Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.1M Buy
711,299
+9,955
+1% +$260K 3.15% 17
2026
Q1 		$19.7M Buy
701,344
+34,339
+5% +$914K 3.66% 15
2025
Q4 		$16.6M Sell
667,005
-30,705
-4% -$774K 3.03% 15
2025
Q3 		$17.8M Buy
697,710
+37,096
+6% +$916K 3.16% 16
2025
Q2 		$16M Buy
660,614
+59,397
+10% +$1.39M 2.94% 17
2025
Q1 		$15.2M Buy
601,217
+7,539
+1% +$197K 2.97% 17
2024
Q4 		$15.8M Buy
593,678
+4,626
+0.8% +$125K 2.94% 18
2024
Q3 		$17M Buy
589,052
+5,989
+1% +$175K 3.18% 17
2024
Q2 		$16.3M Buy
583,063
+32,358
+6% +$891K 3.18% 15
2024
Q1 		$15.3M Buy
550,705
+7,085
+1% +$197K 2.89% 19
2023
Q4 		$15.7M Sell
543,620
-3,585
-0.7% -$108K 3.2% 18
2023
Q3 		$18.2M Buy
547,205
+2,865
+0.5% +$101K 4.05% 13
2023
Q2 		$20M Buy
544,340
+1,005
+0.2% +$39.1K 4.29% 12
2023
Q1 		$22.2M Sell
543,335
-9,591
-2% -$414K 4.98% 9
2022
Q4 		$28.3M Buy
552,926
+2,235
+0.4% +$107K 6.24% 2
2022
Q3 		$24.1M Sell
550,691
-5,747
-1% -$279K 5.79% 5
2022
Q2 		$29.2M Buy
556,438
+231
+0% +$11.8K 6.52% 3
2022
Q1 		$28.8M Buy
556,207
+5,095
+0.9% +$264K 5.75% 4
2021
Q4 		$32.5M Sell
551,112
-160
-0% -$7.93K 6.15% 3
2021
Q3 		$23.7M Sell
551,272
-4,230
-0.8% -$187K 4.91% 7
2021
Q2 		$21.8M Buy
555,502
+6,797
+1% +$264K 4.51% 7
2021
Q1 		$19.9M Buy
+548,705
New +$19.5M 4.35% 11

Other funds holding PFE

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Coerente Capital Management's PFE Position: Q2 2026 in Review

Coerente Capital Management increased its Pfizer (PFE) stake by 1.4% in Q2 2026, buying an estimated $260K and bringing the position to 711,299 shares worth $17.1M. The position accounts for 3.15% of the portfolio, ranked #17.

Coerente Capital Management first reported a position in PFE in Q1 2021 and has held it in 22 quarters since. The position peaked at $32.5M in Q4 2021. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Coerente Capital Management held 711,299 shares of Pfizer worth $17.1M as of Q2 2026.
  • Coerente Capital Management bought 9,955 Pfizer shares in Q2 2026, an estimated $260K.
  • Pfizer made up 3.15% of Coerente Capital Management's portfolio in Q2 2026, its #17 holding.
  • Coerente Capital Management first reported a position in Pfizer in Q1 2021 and has held it in 22 quarters since.
  • Coerente Capital Management's Pfizer position peaked at $32.5M in Q4 2021.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Coerente Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.